A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
| Autor: | Francesco Bussu, Salvatore Rubino, Daniela Pasero, Davide Piredda, Pierpaolo Terragni, Silvana Sanna, Alice Buselli, Raffaella Simeo, Gian Pietro Branca, Corrado Liperi, Davide Rizzo, Lorenzo Casadio |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SARS-Cov-2 030106 microbiology Case Report Disease medicine.disease_cause 03 medical and health sciences 0302 clinical medicine Immune system medicine Mucormycosis Opportunistic infections 030212 general & internal medicine Pulmonary mucormycosis Coronavirus business.industry General Medicine medicine.disease Infectious Diseases Immunology Complication business |
| Zdroj: | Infection |
| ISSN: | 1439-0973 0300-8126 |
| Popis: | Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink